<p>Hello All
I have got admit for MS in Biotechnology at Upenn and MS Biomedical Engineering at Duke university.
Can anyone of you tell me which one is better course from a job prospective??
I am more interested to work in consultancy companies that deals in healthcare sector.Which uni Duke or Upenn will be better option for me
Thanks</p>
<p>I think both would provide you a very good platform to obtain a career in consulting, especially within the healthcare discipline. I don’t think this forum is necessarily the best place to ask such a specific-program question though as most here are focused at the undergrad level. I know Duke’s graduate BME program is considered among the top 5 in the nation; I’m sure UPenn’s biotech program is near the top as well. You can also easily cater your research interests at the graduate level by selecting a lab that fits you more - so, it shouldn’t be a problem to find a more biotech-like research position within Duke’s BME lab, and I’d think Penn’s research spectrum is also relatively broad such that you could find a more biomedical-type lab if it fits your desires more. As long as the research/coursework illustrates some background in the field, I don’t think firms will actually care all that much if your major is biomedical engineering or biotechnology.</p>
<p>Having said all that, I guess you could look at which firms specifically recruit on campus at Duke and UPenn. You can apply to theses firms anyways, but it makes things simpler if the employer already has a relationship with the university and interviews on campus. Here are a few of the top consulting firms that come to my mind that focus on the pharmaceutical & health care industries: ZS Associates, IMS Health, Stockamp & Associates (bought by Huron Consulting recently), and obviously stalwarts McKinsey, Bain, and BCG. I think all of those recruit at both campuses (not sure about IMS Health…), so I think you’re off to a good start. I’d choose based on where you thin you’d enjoy more and not based on career prospects as the difference is probably insignificant. The Raleigh-Durham area is flooded with pharma and biotech firms, though, I should say.</p>
<p>
As is Philly, which is one of the leading pharma/biotech centers in the country. Lots of big pharma companies have headquarters/major facilities within a 50-mile radius of Philly, such as Wyeth, J&J, Merck, GlaxoSmithKline, Teva, and AstraZeneca, just to name a few, in addition to a plethora of smaller biotech firms.</p>